Medical and Pharmaceutical Cancer detection specialist Freenome lists on Nasdaq through special purpose merger Freenome has been developing its blood biopsy platform for more than a decade Rowan DunneJuly 20, 2026
Medical and Pharmaceutical Common workout supplement creatine could strengthen cancer immunotherapy, UCLA study suggests Researchers began by studying dendritic cells taken from mice Joseph MortonJuly 20, 2026
Medical and Pharmaceutical Study explores possible pesticide connection to lung cancer in younger non-smokers Researchers stressed that the study does not suggest healthy foods cause lung cancer Joseph MortonJuly 17, 2026
Medical and Pharmaceutical WHOOP and Kinomatic use their wellness tech to improve joint replacement recovery Minimising opioid use after procedures is a key goal Rowan DunneJuly 15, 2026
Medical and Pharmaceutical Canadian trial to test blood-based cancer detection in 7,000 survivors SHERLOCK will recruit patients who have already undergone treatments intended to cure their disease Joseph MortonJuly 14, 2026
Medical and Pharmaceutical AI-powered light scan could speed up targeted lung cancer treatments This technique, fluorescence lifetime imaging microscopy, could save patients and hospitals alot of money Rowan DunneJuly 13, 2026
Cannabis Tilray’s medical cannabis division enters Panama with CBD shipments The nation's legal sector is small and growing slowly Rowan DunneJuly 13, 2026
Medical and Pharmaceutical Japan’s first robotic surgery system attains CE Mark for European propulsion Milestone builds on Medicaroid inaugurating a new training centre in France last year Rowan DunneJuly 12, 2026
Medical and Pharmaceutical 23andMe breach victims to receive USD$46.75M settlement after bankruptcy ruling The court documents did not specify how many people will ultimately receive compensation Joseph MortonJuly 10, 2026
Medical and Pharmaceutical ClearOne skyrockets from neurotech pivot, merger with Cortigent Cortigent uses brain and retina implant tech to help blind people navigate better Rowan DunneJuly 8, 2026